YasunamiY.; RyuS.; KameiT.FK506 as the sole immunosuppressive agent for prolongation of islet allograft survival in the rat.Transplantation49: 682; 1990.
2.
RyuS.; YasunamiY.Necessity of differential immunosuppression for prevention of immune rejection by FK506 in rat islet allografts transplanted into the liver or beneath the kidney capsule.Transplantation52: 599; 1991.
3.
YasunamiY.; RyuS.; UekiM.; KameiT.; TanakaM.; IkedaS.Donor specific unresponsiveness induced by intraportal grafting and FK506 in rat islet allografts: Importance of low temperature culture and transplant site on induction and maintenance.Cell Transplantation3(1): 7582; 1994.
4.
KameiT.; YasunamiY.; Demonstration of donor specific unresponsiveness in rat islet allografts: Importance of transplant site for induction by cyclosporin A and maintenance.Diabetologia32: 779; 1989.
5.
YasunamiY.; KameiT.; RyuS.; TerasakaR.; KonomiK.Use of mixed islets from two strains as the donor for single transplantation: Induction of donor-specific unresponsiveness to each strain by cyclosporine and intraportal grafting.Transplantation49: 1179; 1990.
6.
PosseltA.; BarkerC.F.; TomaszewskiJ.E.; MarkmannJ.F.; ChotiA.; NajiA.Induction of donor-specific unresponsiveness by intrathymic islet transplantation.Science249: 1293; 1990.
